KISS Medtec and Om Surgical Unveil Partnership to Revolutionize MedTech
United States, Sunday, 19 October 2025.
KISS Medtec and Om Surgical have announced a strategic partnership to boost innovation in medical technology. William Peavey will lead Om Surgical as CEO, enhancing implant systems with advanced marketing across the U.S.
Strategic Partnership Overview
The collaboration between KISS Medtec and Om Surgical, announced on September 27, 2025, marks a significant milestone in the MedTech sector. The partnership aims to leverage each company’s strengths to enhance product development, expand market reach, and ultimately improve patient outcomes. William Peavey, who steps into the role of CEO at Om Surgical, is expected to drive the integration of innovative implant systems with next-gen marketing strategies across the United States [1][2][3].
Leadership and Vision
William Peavey’s leadership is complemented by his brother, Patrick Peavey, who brings experience as a cardiothoracic representative, reinforcing the partnership’s focus on championship-level leadership and strategic growth. Shomit James, the founder of Om Surgical, highlighted the Peavey brothers’ roles in uniting proven implant systems with cutting-edge marketing techniques to redefine the standards of medtech growth [1][2].
Implications for the MedTech Industry
This strategic alliance is poised to accelerate research and development efforts, expand distribution channels, and create new opportunities for healthcare providers nationwide. The partnership is expected to lead to the unveiling of their first joint project in early 2026, with new hires planned across multiple states to support these initiatives [1][3]. This move aligns with the industry trend toward collaborative innovation in response to the growing demand for advanced healthcare solutions [1][4].
Future Prospects and Market Impact
The partnership between KISS Medtec and Om Surgical is anticipated to significantly impact the MedTech landscape by integrating complex designs and ensuring regulatory compliance. The collaboration reflects a commitment to developing new surgical solutions and enhancing medical technology, thereby increasing market competitiveness and improving patient care. Upcoming events, such as the MedTech Innovation Summit in December 2025, will likely showcase the results of this collaborative effort [2][4].